Howard Bernstein

Howard Bernstein

Chief Executive Officer chez SQZ BIOTECHNOLOGIES COMPANY

Fortune : 2 855 $ au 31/03/2024

67 ans
Health Technology
Consumer Services
Electronic Technology

Profil

Howard Bernstein is currently the Chief Executive Officer & Director at SQZ Biotechnologies Co. He is also a Member of the National Academy of Engineering.
Previously, he held positions as Vice President-Pharmaceutical Development at Alkermes, Inc. from 1992 to 1994, Executive VP-Research & Development at Acusphere, Inc. from 1994 to 2008, and Chief Scientific Officer at YourBio Health, Inc. from 2008 to 2015.
Dr. Bernstein obtained his undergraduate degree from McGill University and doctorate degrees from Massachusetts Institute of Technology and Harvard Medical School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2023 59 470 ( 0,20% ) 2 855 $ 31/03/2024

Postes actifs de Howard Bernstein

SociétésPosteDébut
SQZ BIOTECHNOLOGIES COMPANY Chief Executive Officer 30/11/2022
Corporate Officer/Principal -
Tous les postes actifs de Howard Bernstein

Anciens postes connus de Howard Bernstein

SociétésPosteFin
Chief Tech/Sci/R&D Officer 01/05/2015
ACUSPHERE, INC. Chief Tech/Sci/R&D Officer 18/11/2008
Corporate Officer/Principal 01/01/1994
Voir l'expérience en détail de Howard Bernstein

Formation de Howard Bernstein

McGill University Undergraduate Degree
Massachusetts Institute of Technology Doctorate Degree
Harvard Medical School Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Howard Bernstein

Relations

100 +

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ACUSPHERE, INC.

Health Technology

SQZ BIOTECHNOLOGIES COMPANY

Health Technology

Entreprise privées3

Health Technology

Electronic Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Howard Bernstein